Losartan, a blood pressure medication in the angiotensin II receptor blocker (ARB) class, helps reduce blood pressure by preventing blood vessels from narrowing or constricting.

Since July 2018, there have been a string of recalls related to three common generic heart drugs — losartan, irbesartan and valsartan — due to the detection of probable human carcinogens.

Two pharmaceutical companies are expanding the recent recalls of a variety of blood pressure medications.

Amlodipine and hydrochlorothiazide in standalone form are not subject to the recall. ... Several pharmaceutical companies have announced recalls of versions of valsartan, irbesartan and losartan.

In December Aurobindo Pharma USA had announced a voluntary recall of 80 lots of amlodipine valsartan tablets, valsartan tablets with the diuretic hydrochlorothiazide, and valsartan tablets due to ...

Torrent Pharmaceuticals Limited is expanding its voluntary recall from two lots of losartan potassium tablets to a total of 10 lots, according to a Jan. 3 company announcement on the Food and Drug ...

This study assessed the antihypertensive efficacy of a triple combination, fixed-dose therapy of losartan 50 mg (L50)/hydrochlorothiazide 12.5 mg (H12.5)/amlodipine 5 mg (A5) versus co ...

WATCH. 85 °. WATCH News Weather Video 11 Investigates Sports Decision 2024 11 Cares Olympics Changing Climate Home Experts Care Connect Breaking the Stigma Steals and Deals ...